Still happy to risk $1bn on p=0.05?
This article was originally published in Scrip
Executive Summary
How would all of you out there in Pharmaland feel if a paper published in a reputable science journal suggested that clinical trials were a bogus way of gathering information to decide whether to progress a given compound towards the clinic?